SCHEMBL7974580

SCHEMBL7974580

NC(=O)C(=O)Nc1ccccc1C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.57
DHODH Q02127 3/20 0.57
TRPM8 Q7Z2W7 1/20 0.57
MAPT P10636 1/20 0.57
CTSK P43235 1/20 0.57
TRPA1 O75762 1/20 0.55
PKM P14618 2/20 0.54
MEN1 O00255 2/20 0.54
MASP2 O00187 1/20 0.53
CFD P00746 1/20 0.51
FABP4 P15090 1/20 0.50
LMNA P02545 1/20 0.50
ABCC1 P33527 2/20 0.49
ALDH1A1 P00352 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM4E B2RXH2 1/20 0.49
POLB P06746 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13936398 0.88 DHODH (0.64) KMT2ADHODHTRPM8MAPTCTSK
SCHEMBL27971661 0.86 KDM4E (0.59) KMT2AMAPTPKMMEN1LMNA
SCHEMBL6326283 0.86 KMT2A (0.62) KMT2ADHODHTRPM8MAPTCTSK
SCHEMBL30583240 0.84 PTPN1 (0.64) KMT2ADHODHTRPM8TRPA1PKM
SCHEMBL4315667 0.84 PTPN1 (0.64) KMT2ADHODHTRPM8TRPA1PKM
SCHEMBL27580953 0.84 ALDH1A1 (0.59) KMT2AMAPTTRPA1PKMMEN1
SCHEMBL11132128 0.83 NPC1 (0.52) KMT2AMAPTMEN1LMNAALDH1A1
SCHEMBL7846234 0.83 KMT2A (0.55) KMT2ADHODHTRPM8MAPTCTSK
SCHEMBL3627546 0.81 MASP2 (0.62) KMT2ADHODHMAPTCTSKPKM
SCHEMBL233797 0.81 KMT2A (0.57) KMT2ADHODHTRPM8MAPTCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1062199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP claimed
WO-1999046236-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO claimed
US-6225329-B1 USEFUL IN THE TREATMENT OF TYPE I DIABETES, TYPE II DIABETES, IMPAIRED GLUCOSE TOLERANCE, INSULIN AUTOIMMUNITY DISEASES WITH DYSFUNCTIONS OF THE COAGULATION SYSTEM, ALLERGIC DISEASES NOVO NORDISK A/S (DK) 2001-05-01 US disclosed
EP-1062199-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2000-12-27 EP disclosed
WO-1999046236-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 1999-09-16 WO disclosed